A cohort study evaluating a tuberculosis (TB) prevention program among patients who received biologic therapy found a low risk for incident infection. Pretreatment screening with QuantiFERON-TB (QFT) ...
New study supports QuantiFERON-TB Gold Plus use in immunocompromised and other high-risk populations in various settings Findings show QuantiFERON testing is cost-effective compared with tuberculin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results